Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Don't have an account? Register Here
<h1>DGFT Clarifies Import Procedure for Drugs Under Advance Licensing: Re-export, Manufacture, or Supervised Destruction Options Available.</h1> The Directorate General of Foreign Trade has issued a clarification on the procedure for importing approved and unapproved drugs under the Advance Licensing Scheme. If an exporter fails to export the resultant product, they must re-export the imported material to satisfy Customs Authorities. The revised policy allows exporters to use imported materials for manufacturing other export products or re-export them, fulfilling export obligations. Unregistered raw materials cannot be used domestically. If the export obligation period expires, a composition fee for extension is required. Alternatively, inputs or finished products can be destroyed under supervision, with necessary documentation submitted to the Regional Authority.